Testing the feasibility of a national respiratory swabbing tool in FluSurvey to support pandemic preparedness in England, 2025-26
Wolmuth-Gordon, H.; Lachhani, M.; Pebody, R.; Amirthalingam, G.; Green, R. E.; Dabrera, G.
Show abstract
Background FluSurvey is a participatory surveillance system, through which participants report weekly respiratory symptoms, healthcare use and social contacts. To support rapid public health assessment we developed a respiratory self-swabbing feature. We aimed to assess the feasibility of self-swabbing among symptomatic FluSurvey participants. Methods FluSurvey self-swabbing was deployed in England between January-March 2026. Adults reporting recent Acute Respiratory Infection symptoms were eligible for a self-swabbing Covid-19, RSV and Influenza PCR test which was returned to the laboratory by post. Participants were sent optional feedback surveys. We described swabbing interest, timeliness and participant demographics. We evaluated participant feedback to improve the process. Results There were 234 eligible illnesses during the study period; 45.7% (107/234) requested test kits and 93.5%(100/107) test kits were returned. Of these, 97.0%(97/100) had valid results; median participant age was 61.74 years (IQR:47.4-67.4), 68.4% were female and 90.0% were of white ethnicity. All nine regions in England were represented. Timeliness was high; the median time from symptom onset to specimen date was 4.0 days (IQR:3.0-5.0). Of participants completing feedback surveys, 96.7%(59/61) would consider participating in self-swabbing again. Conclusions We developed a tool to test individuals, often not presenting to healthcare, for respiratory viruses using an established community-based surveillance system. This tool can be rapidly deployed and adapted to public health need, to assess community-based emerging respiratory or pandemic infections. The high return rate and positive feedback suggest continued engagement of the cohort in respiratory virus swabbing.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- A Remote Household-Based Approach to Influenza Self-Testing and Antiviral Treatment 92%
- Cohort Profile: a Prospective Household cohort study of Influenza, Respiratory Syncytial virus, and other respiratory pathogens community burden and Transmission dynamics in South Africa (PHIRST), 2016-2018 92%
- Home collection of nasal swabs for detection of influenza in the Household Influenza Vaccine Evaluation Study 90%
Similar papers in this journal
- Electronic data capture for large scale typhoid surveillance, household contact tracing, and health utilisation survey: Strategic Typhoid Alliance across Africa and Asia. 90%
- Sensitivity of RT-PCR testing of upper respiratory tract samples for SARS-CoV-2 in hospitalised patients: a retrospective cohort study. 90%
- Impact of baseline cases of cough and fever on UK COVID-19 diagnostic testing rates: estimates from the Bug Watch community cohort study 89%
Similar papers in this journal
- Social contacts and other risk factors for respiratory infections among internally displaced people in Somaliland 89%
- Characterizing Co-Circulating Respiratory Virus Genomic Diversity in Switzerland with Hybrid-Capture Sequencing and Phylogenetic Reconstructions: Insights into the 2023/24 Season 89%
- Coughs, Colds and “Freshers’ Flu” Survey in the University of Cambridge, 2007-2008 88%
Similar papers in this journal
- Flexible and scalable participatory syndromic and virological surveillance for respiratory infections: our experiences in The Netherlands 92%
- A prospective diagnostic evaluation of accuracy of self-taken and healthcare worker-taken swabs for rapid COVID-19 testing 92%
- Adapting COVID-19 research infrastructure to capture influenza and RSV alongside SARS-CoV-2 in UK healthcare workers winter 2022/23: Evaluation of the SIREN Winter Pressures pilot study 91%
Similar papers in this journal
- Dutch participatory surveillance framework for evaluating evolutionary changes on SARS-CoV-2 affecting Rapid Diagnostic Test sensitivity in 2022 - 2023. 93%
- Severe Acute Respiratory Syndrome Coronavirus-2 seropositivity in South-Central Uganda, during 2019 - 2021 90%
- Diagnostic performance of the combined nasal and throat swab in patients admitted to hospital with suspected COVID-19 90%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.